Roberto Pili

  • 10771 Citations
  • 51 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1990 2019

44 Citations (Scopus)

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage

Ciamporcero, E., Shen, H., Ramakrishnan, S., Yu Ku, S., Chintala, S., Shen, L., Adelaiye, R., Miles, K. M., Ullio, C., Pizzimenti, S., Daga, M., Azabdaftari, G., Attwood, K., Johnson, C., Zhang, J., Barrera, G. & Pili, R., Mar 24 2016, In : Oncogene. 35, 12, p. 1541-1553 13 p.

Research output: Contribution to journalArticle

DNA Damage
Carcinoma
Proteins
Cisplatin
Drug Therapy
88 Citations (Scopus)

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago phase 2 consortium

Bradley, D., Rathkopf, D., Dunn, R., Stadler, W. M., Liu, G., Smith, D. C., Pili, R., Zwiebel, J., Scher, H. & Hussain, M., Jan 12 2009, In : Cancer. 115, 23, p. 5541-5549 9 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Interleukin-6
Prostatic Neoplasms
Clinical Trials
Drug Therapy
96 Citations (Scopus)

Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: Results of a large phase 2 study

Vaughn, D. J., Srinivas, S., Stadler, W. M., Pili, R., Petrylak, D., Sternberg, C. N., Smith, D. C., Ringuette, S., De Wit, E., Pautret, V. & George, C., Sep 15 2009, In : Cancer. 115, 18, p. 4110-4117 8 p.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Advisory Committees
Disease Progression
Karnofsky Performance Status
35 Citations (Scopus)

VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo

Kolmakova, A., Rajesh, M., Zang, D., Pili, R. & Chatterjee, S., Jul 2009, In : Glycoconjugate Journal. 26, 5, p. 547-558 12 p.

Research output: Contribution to journalArticle

Endothelial cells
Cell Adhesion Molecules
Vascular Endothelial Growth Factor A
Endothelial Cells
CD31 Antigens
146 Citations (Scopus)

VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo

Muhlhauser, J., Merrill, M. J., Pili, R., Maeda, H., Bacic, M., Bewig, B., Passaniti, A., Edwards, N. A., Crystal, R. G. & Capogrossi, M. C., 1995, In : Circulation Research. 77, 6, p. 1077-1086 10 p.

Research output: Contribution to journalArticle

Human Umbilical Vein Endothelial Cells
Adenoviridae
Vascular Endothelial Growth Factor A
Smooth Muscle Myocytes
Aorta
111 Citations (Scopus)

Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model

Verheul, H. M. W., Hammers, H., Van Erp, K., Wei, Y., Sanni, T., Salumbides, B., Qian, D. Z., Yancopoulos, G. D. & Pili, R., Jul 15 2007, In : Clinical Cancer Research. 13, 14, p. 4201-4208 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Vascular Endothelial Growth Factor A
Blood Vessels
Neoplasm Metastasis
Growth
13 Citations (Scopus)

Vascular disruption in combination with mTOR inhibition in renal cell carcinoma

Ellis, L., Shah, P., Hammers, H., Lehet, K., Sotomayor, P., Azabdaftari, G., Seshadri, M. & Pili, R., Feb 2012, In : Molecular Cancer Therapeutics. 11, 2, p. 383-392 10 p.

Research output: Contribution to journalArticle

vadimezan
Renal Cell Carcinoma
Blood Vessels
Neoplasms
Heterografts
3 Citations (Scopus)

Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.

Translated title of the contribution: Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasmsGuidi, L., Bartoloni, C., Pellicanò, P., Cappelli, A., Cursi, F., Pili, R., Tricerri, A., Patriarca, F. & Gambassi, G., Mar 31 1991, In : Clinica Terapeutica. 136, 6, p. 367-373 7 p.

Research output: Contribution to journalArticle

Gastrointestinal Neoplasms
Blood Coagulation
Neoplasms
Enzyme-Linked Immunosorbent Assay
antithrombin III-protease complex
13 Citations (Scopus)

Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model

Chatterjee, S., Alsaeedi, N., Hou, J., Bandaru, V. V. R., Wu, L., Halushka, M. K., Pili, R., Ndikuyeze, G. & Haughey, N. J., May 9 2013, In : PLoS One. 8, 5, e63726.

Research output: Contribution to journalArticle

kidney neoplasms
Glycosphingolipids
Kidney Neoplasms
glycolipids
Glycolipids
18 Citations (Scopus)

Update on novel agents in renal cell carcinoma

Tamaskar, I. & Pili, R., Dec 2009, In : Expert Review of Anticancer Therapy. 9, 12, p. 1817-1827 11 p.

Research output: Contribution to journalReview article

Renal Cell Carcinoma
Therapeutics
Standard of Care
Natural History
Drug Resistance
26 Citations (Scopus)

Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer

Rehman, S., Crane, A., Din, R., Raza, S. J., Shi, Y., Wilding, G., Levine, E. G., George, S., Pili, R., Trump, D. L. & Guru, K. A., Dec 2013, In : Urology. 82, 6, p. 1370-1375 6 p.

Research output: Contribution to journalArticle

Cystectomy
Urinary Bladder Neoplasms
Drug Therapy
Referral and Consultation
Medical Oncology
4 Citations (Scopus)

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Adra, N., Cheng, L. & Pili, R., Dec 17 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Kidney Neoplasms
Renal Cell Carcinoma
Immunotherapy
Therapeutics
nivolumab
37 Citations (Scopus)

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

Kirk, J. S., Schaarschuch, K., Dalimov, Z., Lasorsa, E., Ku, S. Y., Ramakrishnan, S., Hu, Q., Azabdaftari, G., Wang, J., Pili, R. & Ellis, L., 2015, In : Oncotarget. 6, 5, p. 3136-3146 11 p.

Research output: Contribution to journalArticle

Epigenomics
Prostatic Neoplasms
Etoposide
Therapeutics
Neoplasms
169 Citations (Scopus)

The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth

Pili, R., Chang, J., Partis, R. A., Mueller, R. A., Chrest, F. J. & Passaniti, A., Jul 1 1995, In : Cancer Research. 55, 13, p. 2920-2926 7 p.

Research output: Contribution to journalArticle

Glycosylation
Endothelial Cells
Mannose
Glucosidases
Oligosaccharides
30 Citations (Scopus)

The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell Carcinoma

Verheul, H. M. W., van Erp, K., Homs, M. Y. V., Yoon, G. S., van Der Groep, P., Rogers, C., Hansel, D. E., Netto, G. J. & Pili, R., Mar 2010, In : Urology. 75, 3, p. 608-614 7 p.

Research output: Contribution to journalArticle

Blood Coagulation Factors
Fibrin
Renal Cell Carcinoma
Fibrinogen
Vascular Endothelial Growth Factor A
8 Citations (Scopus)

Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma

Damayanti, N. P., Budka, J. A., Khella, H. W. Z., Ferris, M. W., Ku, S. Y., Kauffman, E., Wood, A. C., Ahmed, K., Chintala, V. N., Adelaiye-Ogala, R., Elbanna, M., Orillion, A., Chintala, S., Kao, C., Marston Linehan, W., Yousef, G. M., Hollenhorst, P. C. & Pili, R., Dec 1 2018, In : Clinical Cancer Research. 24, 23, p. 5977-5989 13 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Renal Cell Carcinoma
Therapeutics
S 6
High-Throughput Nucleotide Sequencing
6 Citations (Scopus)

Therapeutic targeting of sunitinib-induced AR phosphorylation in renal cell carcinoma

Adelaiye-Ogala, R., Damayanti, N. P., Orillion, A. R., Arisa, S., Chintala, S., Titus, M. A., Kao, C. & Pili, R., Jun 1 2018, In : Cancer Research. 78, 11, p. 2886-2896 11 p.

Research output: Contribution to journalArticle

Androgen Receptors
Renal Cell Carcinoma
Phosphorylation
Therapeutics
Receptor Protein-Tyrosine Kinases
77 Citations (Scopus)

The N-Myc down regulated gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin

Kachhap, S. K., Faith, D., Qian, D. Z., Shabbeer, S., Galloway, N. L., Pili, R., Denmeade, S. R., DeMarzo, A. M. & Carducci, M. A., Sep 5 2007, In : PLoS One. 2, 9, e844.

Research output: Contribution to journalArticle

cadherins
Recycling
Cadherins
recycling
Transferrin
193 Citations (Scopus)

The histone deacetylase inhibitor NVP-LAQ824 Inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584

Qian, D. Z., Wang, X., Kachhap, S. K., Kato, Y., Wei, Y., Zhang, L., Atadja, P. & Pili, R., Sep 15 2004, In : Cancer Research. 64, 18, p. 6626-6634 9 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Histone Deacetylase Inhibitors
Protein-Tyrosine Kinases
Neoplasms
Vascular Endothelial Growth Factor A
134 Citations (Scopus)

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

Keizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M. A., Pili, R., Hammers, H. & Carducci, M. A., Jan 2012, In : European Journal of Cancer. 48, 2, p. 202-208 7 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Disease-Free Survival
Neutrophils
Lymphocytes
Survival
60 Citations (Scopus)

Testicular cancer, version 2.2015: Clinical pactice guidelines in oncology

Motzer, R. J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Gupta, S., Hancock, S. L., Kim, J. J., Kuzel, T. M., Lam, E. T., Lau, C., Levine, E. G., Lin, D. W., Michaelson, M. D., Olencki, T. & 12 others, Pili, R., Plimack, E. R., Rampersaud, E. N., Redman, B. G., Ryan, C. J., Sheinfeld, J., Shuch, B., Sircar, K., Somer, B., Wilder, R. B., Dwyer, M. & Kumar, R., Jun 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 6, p. 772-799 28 p.

Research output: Contribution to journalReview article

Seminoma
Testicular Neoplasms
Guidelines
Germ Cell and Embryonal Neoplasms
Serum
80 Citations (Scopus)

Testicular cancer

Motzer, R. J., Agarwal, N., Beard, C., Bolger, G. B., Boston, B., Carducci, M. A., Choueiri, T. K., Figlin, R. A., Fishman, M., Hancock, S. L., Hudes, G. R., Jonasch, E., Kessinger, A., Kuzel, T. M., Lange, P. H., Levine, E. G., Margolin, K. A., Michaelson, M. D., Olencki, T., Pili, R. & 5 others, Redman, B. G., Robertson, C. N., Schwartz, L. H., Sheinfeld, J. & Wang, J., Jun 2009, In : JNCCN Journal of the National Comprehensive Cancer Network. 7, 6, p. 672-693 22 p.

Research output: Contribution to journalReview article

Testicular Neoplasms
Germ Cell and Embryonal Neoplasms
Neoplasms
Seminoma
Carboplatin
47 Citations (Scopus)

Testicular cancer

Motzer, R. J., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Buyyounouski, M. K., Carducci, M. A., Chang, S. S., Choueiri, T. K., Gupta, S., Hancock, S. L., Hudes, G. R., Jonasch, E., Kuzel, T. M., Lau, C., Levine, E. G., Lin, D. W., Margolin, K. A., Michaelson, M. D., Olencki, T. & 8 others, Pili, R., Ratliff, T. W., Redman, B. G., Robertson, C. N., Ryan, C. J., Sheinfeld, J., Wang, J. & Wilder, R. B., Apr 1 2012, In : JNCCN Journal of the National Comprehensive Cancer Network. 10, 4, p. 502-535 34 p.

Research output: Contribution to journalReview article

Tasquinimod targets suppressive myeloid cells in the tumor microenvironment

Shen, L. & Pili, R., May 3 2018, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticle

Tumor Microenvironment
Myeloid Cells
Immunosuppressive Agents
Macrophages
Population
46 Citations (Scopus)

Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models

Shen, L., Sundstedt, A., Ciesielski, M., Miles, K. M., Celander, M., Adelaiye, R., Orillion, A., Ciamporcero, E., Ramakrishnan, S., Ellis, L., Fenstermaker, R., Abrams, S. I., Eriksson, H., Leanderson, T., Olsson, A. & Pili, R., Feb 1 2015, In : Cancer immunology research. 3, 2, p. 136-148 13 p.

Research output: Contribution to journalArticle

Myeloid Cells
Immunotherapy
Neoplasms
Immunosuppressive Agents
Prostatic Neoplasms
5 Citations (Scopus)

Tasquinimod: A novel angiogenesis inhibitor-development in prostate cancer

George, S. & Pili, R., Apr 2013, In : Current Oncology Reports. 15, 2, p. 65-68 4 p.

Research output: Contribution to journalArticle

Angiogenesis Inhibitors
Prostatic Neoplasms
Castration
Therapeutics
Drug Therapy
151 Citations (Scopus)

Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: Therapy with sequential 1-β -D-arabinofuranosylcytosine, mitoxantrone, and bevacizumab

Karp, J. E., Gojo, I., Pili, R., Gocke, C. D., Greer, J., Guo, C., Qian, D., Morris, L., Tidwell, M., Chen, H. & Zwiebel, J., Jun 1 2004, In : Clinical Cancer Research. 10, 11, p. 3577-3585 9 p.

Research output: Contribution to journalArticle

Mitoxantrone
Cytarabine
Acute Myeloid Leukemia
Vascular Endothelial Growth Factor A
Therapeutics
222 Citations (Scopus)

Targeting tumor angiogenesis with histone deacetylase inhibitors: The hydroxamic acid derivative LBH589

Qian, D. Z., Kato, Y., Shabbeer, S., Wei, Y., Verheul, H. M. W., Salumbides, B., Sanni, T., Atadja, P. & Pili, R., Jan 15 2006, In : Clinical Cancer Research. 12, 2, p. 634-642 9 p.

Research output: Contribution to journalArticle

Hydroxamic Acids
Histone Deacetylase Inhibitors
Neoplasms
Acetylation
Human Umbilical Vein Endothelial Cells
169 Citations (Scopus)

Targeting tumor angiogenesis with histone deacetylase inhibitors

Ellis, L., Hammers, H. & Pili, R., Aug 8 2009, In : Cancer Letters. 280, 2, p. 145-153 9 p.

Research output: Contribution to journalShort survey

Histone Deacetylase Inhibitors
Hypoxia-Inducible Factor 1
Histone Deacetylases
Neoplasms
Vascular Endothelial Growth Factor A
12 Citations (Scopus)

Targeting the programmed cell death-1 pathway in genitourinary tumors: Current progress and future perspectives

Mann, S. A., Lopez-Beltran, A., Massari, F., Pili, R., Fiorentino, M., Koch, M., Kaimakliotis, H., Wang, L., Scarpelli, M., Ciccarese, C., Moch, H., Montironi, R. & Cheng, L., Jan 1 2017, In : Current Drug Metabolism. 18, 8, p. 700-711 12 p.

Research output: Contribution to journalReview article

Cell death
Tumors
Cell Death
Immunohistochemistry
Assays

TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)

Bunch, B., Krishnan, N., Greenspan, R. D., Ramakrishnan, S., Attwood, K., Yan, L., Qi, Q., Wang, D., Morrison, C., Omilian, A., Bshara, W., Pili, R., Trump, D. L., Johnson, C. & Woloszynska, A., Sep 2 2019, In : Cell Cycle. 18, 17, p. 2055-2066 12 p.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Methylation
Cisplatin
decitabine
Muscles
61 Citations (Scopus)

Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma

Kato, Y., Yoshimura, K., Shin, T., Verheul, H., Hammers, H., Sanni, T. B., Salumbides, B. C., Van Erp, K., Schulick, R. & Pili, R., Aug 1 2007, In : Clinical Cancer Research. 13, 15, p. 4538-4546 9 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Renal Cell Carcinoma
Interleukin-2
Therapeutics
Regulatory T-Lymphocytes
40 Citations (Scopus)

Symptoms, supportive care needs, and function in cancer patients: How are they related?

Snyder, C. F., Garrett-Mayer, E., Brahmer, J. R., Carducci, M. A., Pili, R., Stearns, V., Wolff, A. C., Dy, S. M. & Wu, A. W., Jun 2008, In : Quality of Life Research. 17, 5, p. 665-677 13 p.

Research output: Contribution to journalArticle

Health Information Systems
Appetite
Psychology
Cognition
Fatigue
35 Citations (Scopus)

Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications

Adelaiye, R., Ciamporcero, E., Miles, K. M., Sotomayor, P., Bard, J., Tsompana, M., Conroy, D., Shen, L., Ramakrishnan, S., Ku, S. Y., Orillion, A., Prey, J., Fetterly, G., Buck, M., Chintala, S., Bjarnasone, G. A. & Pili, R., Feb 1 2015, In : Molecular Cancer Therapeutics. 14, 2, p. 513-522 10 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Epigenomics
sunitinib
Neoplasms
Histone Code
1 Citation (Scopus)

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA

Gawroński, A. R., Lin, Y. Y., McConeghy, B., LeBihan, S., Asghari, H., Koçkan, C., Orabi, B., Adra, N., Pili, R., Collins, C. C., Sahinalp, S. C. & Hach, F., Apr 23 2019, In : Nucleic acids research. 47, 7, p. e38

Research output: Contribution to journalArticle

Open Access
DNA
Neoplasms
Clone Cells
Workflow
Prostatic Neoplasms
17 Citations (Scopus)

Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs

Verheul, H. M. W., Qian, D. Z., Carducci, M. A. & Pili, R., Aug 2007, In : Cancer Chemotherapy and Pharmacology. 60, 3, p. 329-339 11 p.

Research output: Contribution to journalArticle

NSC 153174
Phenylbutyrates
Tretinoin
Cell Cycle
Cells
10 Citations (Scopus)

Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device

Huang, W., Chang, C. L., Brault, N. D., Gur, O., Wang, Z., Jalal, S., Low, P. S., Ratliff, T. L., Pili, R. & Savran, C. A., 2017, In : Lab on a Chip - Miniaturisation for Chemistry and Biology. 17, 3, p. 415-428 14 p.

Research output: Contribution to journalArticle

Biomarkers
Antigens
Prostatic Neoplasms
Cells
Proteins
9 Citations (Scopus)

Selenomethionine and methyl selenocysteine: Multiple-dose pharmacokinetics in selenium-replete men

Marshall, J. R., Burk, R. F., Ondracek, R. P., Hill, K. E., Perloff, M., Davis, W., Pili, R., George, S. & Bergan, R., 2017, In : Oncotarget. 8, 16, p. 26312-26322 11 p.

Research output: Contribution to journalArticle

Selenomethionine
Selenium
Pharmacokinetics
Neoplasms
Yeasts
22 Citations (Scopus)

Role of immunotherapy for renal cell cancer in 2011

George, S., Pili, R., Carducci, M. A. & Kim, J. J., Sep 1 2011, In : JNCCN Journal of the National Comprehensive Cancer Network. 9, 9, p. 1011-1018 8 p.

Research output: Contribution to journalReview article

Renal Cell Carcinoma
Immunotherapy
Interferons
Interleukin-2
Sirolimus
122 Citations (Scopus)

Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: Evidence from a xenograft study

Hammers, H. J., Verheul, H. M., Salumbides, B., Sharma, R., Rudek, M., Jaspers, J., Shah, P., Ellis, L., Shen, L., Paesante, S., Dykema, K., Furge, K., Teh, B. T., Netto, G. & Pili, R., Jun 2010, In : Molecular Cancer Therapeutics. 9, 6, p. 1525-1535 11 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Renal Cell Carcinoma
Heterografts
Pericytes
Neoplasms
20 Citations (Scopus)

Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model

Lamming, D. W., Cummings, N. E., Rastelli, A. L., Gao, F., Cava, E., Bertozzi, B., Spelta, F., Pili, R. & Fontana, L., 2015, In : Oncotarget. 6, 31, p. 31233-31240 8 p.

Research output: Contribution to journalArticle

Dietary Proteins
Heterografts
Fasting
Neoplasms
Proteins
25 Citations (Scopus)

Resistance to angiogenesis inhibitors in renal cell carcinoma

Tamaskar, I., Dhillon, J. & Pili, R., Feb 2011, In : Clinical Advances in Hematology and Oncology. 9, 2, p. 101-110 10 p.

Research output: Contribution to journalArticle

Angiogenesis Inhibitors
Renal Cell Carcinoma
Vascular Endothelial Growth Factor A
Clinical Trials
Tumor Escape
22 Citations (Scopus)

Reproducibility of tumor blood flow quantification with15O-water PET

Lodge, M. A., Jacene, H. A., Pili, R. & Wahl, R. L., Oct 1 2008, In : Journal of Nuclear Medicine. 49, 10, p. 1620-1627 8 p.

Research output: Contribution to journalArticle

Water
Neoplasms
Isotopes
Half-Life
Pharmaceutical Preparations
22 Citations (Scopus)
Dihydrotestosterone
Prostate-Specific Antigen
Extracellular Matrix
Carcinoma
Gene Expression
2 Citations (Scopus)
Histone Deacetylase Inhibitors
Histone Deacetylases
Kidney Neoplasms
Enzyme Inhibitors
Acetylation
2 Citations (Scopus)

Real-Time Multiplex Kinase Phosphorylation Sensors in Living Cells

Damayanti, N. P., Buno, K., Cui, Y., Voytik-Harbin, S. L., Pili, R., Freeman, J. & Irudayaraj, J. M. K., Aug 25 2017, In : ACS Sensors. 2, 8, p. 1225-1230 6 p.

Research output: Contribution to journalArticle

phosphorylation
Phosphorylation
Phosphotransferases
Cells
sensors
59 Citations (Scopus)

Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer

Weiss, A., Ding, X., van Beijnum, J. R., Wong, I., Wong, T. J., Berndsen, R. H., Dormond, O., Dallinga, M., Shen, L., Schlingemann, R. O., Pili, R., Ho, C. M., Dyson, P. J., van den Bergh, H., Griffioen, A. W. & Nowak-Sliwinska, P., Jul 20 2015, In : Angiogenesis. 18, 3, p. 233-244 12 p.

Research output: Contribution to journalArticle

Drug Combinations
Endothelial cells
Endothelial Cells
Pharmaceutical Preparations
Neoplasms
42 Citations (Scopus)

Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer

Sternberg, C., Armstrong, A., Pili, R., Ng, S., Huddart, R., Agarwal, N., Khvorostenko, D., Lyulko, O., Brize, A., Vogelzang, N., Delva, R., Harza, M., Thanos, A., James, N., Werbrouck, P., Bögemann, M., Hutson, T., Milecki, P., Chowdhury, S., Gallardo, E. & 6 others, Schwartsmann, G., Pouget, J. C., Baton, F., Nederman, T., Tuvesson, H. & Carducci, M., Aug 1 2016, In : Journal of Clinical Oncology. 34, 22, p. 2636-2643 8 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Placebos
Survival
Disease-Free Survival
5 Citations (Scopus)

Psychological status of institutionalized aged: Influences on immune parameters and endocrinological correlates

Bartoloni, C., Guidi, L., Antico, L., Pili, R., Cursi, F., Carbonin, P., Gambassi, G., Rumi, C., Di Giovanni, A., Menichella, G., Menini, E., Doria, D. F. G. & Doria, G., 1990, In : International Journal of Neuroscience. 51, 3-4, p. 279-281 3 p.

Research output: Contribution to journalArticle

Psychiatric Status Rating Scales
Lymphocyte Subsets
Delayed Hypersensitivity
Lymphocyte Activation
Natural Killer Cells
4 Citations (Scopus)

Psychological status and immunological parameters of institutionalized aged.

Bartoloni, C., Guidi, L., Antico, L., Pariante, C. M., Di Giovanni, A., Pili, R., Cursi, F., Tricerri, A., Tempesta, E. & Frasca, D., Jul 1991, In : Panminerva Medica. 33, 3, p. 164-169 6 p.

Research output: Contribution to journalArticle

Phytohemagglutinins
Psychology
Lymphocytes
Delayed Hypersensitivity
Lymphocyte Activation